<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31595953</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>R2</Issue><PubDate><Year>2019</Year><Month>Nov</Month><Day>21</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Inherited and Sporadic Amyotrophic Lateral Sclerosis and Fronto-Temporal Lobar Degenerations arising from Pathological Condensates of Phase Separating Proteins.</ArticleTitle><Pagination><StartPage>R187</StartPage><EndPage>R196</EndPage><MedlinePgn>R187-R196</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/ddz162</ELocationID><Abstract><AbstractText>Recent work on the biophysics of proteins with low complexity, intrinsically disordered domains that have the capacity to form biological condensates has profoundly altered the concepts about the pathogenesis of inherited and sporadic neurodegenerative disorders associated with pathological accumulation of these proteins. In the present review, we use the FUS, TDP-43 and A11 proteins as examples to illustrate how missense mutations and aberrant post-translational modifications of these proteins cause amyotrophic lateral sclerosis (ALS) and fronto-temporal lobar degeneration (FTLD).</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fernandopulle</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cambridge Institute for Medical Research, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK, CB2 0XY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>GuoZhen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cambridge Institute for Medical Research, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK, CB2 0XY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nixon-Abell</LastName><ForeName>Jonathon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cambridge Institute for Medical Research, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK, CB2 0XY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qamar</LastName><ForeName>Seema</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cambridge Institute for Medical Research, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK, CB2 0XY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balaji</LastName><ForeName>Varun</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, and Departments of Medicine, University of Toronto, Toronto, Ontario, Canada, M5S 3H2.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morihara</LastName><ForeName>Ryuta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, and Departments of Medicine, University of Toronto, Toronto, Ontario, Canada, M5S 3H2.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St George-Hyslop</LastName><ForeName>Peter H</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Cambridge Institute for Medical Research, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK, CB2 0XY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, and Departments of Medicine, University of Toronto, Toronto, Ontario, Canada, M5S 3H2.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>CAPMC</Acronym><Agency> CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017302">Annexins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017302" MajorTopicYN="N">Annexins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001692" MajorTopicYN="N">Biological Transport</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="N">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007425" MajorTopicYN="N">Intracellular Membranes</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013702" MajorTopicYN="N">Temporal Lobe</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ANXA11</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">biological condensates</Keyword><Keyword MajorTopicYN="N">fronto-temporal dementia</Keyword><Keyword MajorTopicYN="N">gelation</Keyword><Keyword MajorTopicYN="N">hydrogels</Keyword><Keyword MajorTopicYN="N">local RNA translation</Keyword><Keyword MajorTopicYN="N">neuronal transport granules</Keyword><Keyword MajorTopicYN="N">phase separation</Keyword><Keyword MajorTopicYN="N">stress granules</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31595953</ArticleId><ArticleId IdType="pmc">PMC6872449</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddz162</ArticleId><ArticleId IdType="pii">5584074</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sivasathiaseelan H., Marshall C.R., Agustus J.L., Benhamou E., Bond R.L., Leeuwen J.E.P., Hardy C.J.D., Rohrer J.D. and Warren J.D. (2019) Frontotemporal Dementia: A Clinical Review. Semin Neurol, 39, 251&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">30925617</ArticleId></ArticleIdList></Reference><Reference><Citation>Couratier P., Corcia P., Lautrette G., Nicol M. and Marin B. (2017) ALS and frontotemporal dementia belong to a common disease spectrum. Rev Neurol (Paris), 173, 273&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pubmed">28449882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng A.S., Rademakers R. and Miller B.L. (2015) Frontotemporal dementia: a bridge between dementia and neuromuscular disease. Ann N Y Acad Sci, 1338, 71&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4399703</ArticleId><ArticleId IdType="pubmed">25557955</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomen-Hoerth C., Anderson T. and Miller B. (2002) The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology, 59, 1077&#x2013;1079.</Citation><ArticleIdList><ArticleId IdType="pubmed">12370467</ArticleId></ArticleIdList></Reference><Reference><Citation>Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H. and Berg L.H. (2017) Amyotrophic lateral sclerosis. Lancet, 390, 2084&#x2013;2098.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A. and Hardiman O. (2013) The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol, 9, 617&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffaele F., Claudia M. and John H. (2019) Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues. Neurobiol Aging, 78, 98&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">30925302</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovici G.D. and Miller B.L. (2010) Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs, 24, 375&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916644</ArticleId><ArticleId IdType="pubmed">20369906</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M. and Brown R.H. Jr. (2018) Genetics of amyotrophic lateral sclerosis. Cold Spring Harb Perspect Med, 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5932579</ArticleId><ArticleId IdType="pubmed">28270533</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S., Stauffer J.E., Schulte D.J. and Ravits J. (2015) Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol Clin, 33, 855&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4628785</ArticleId><ArticleId IdType="pubmed">26515626</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B. and Robberecht W. (2014) The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol, 10, 661&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiryaki E. and Horak H.A. (2014) ALS and other motor neuron diseases. Continuum (Minneap Minn), 20, 1185&#x2013;1207.</Citation><ArticleIdList><ArticleId IdType="pubmed">25299277</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M. and Mackenzie I.R.A. (2019) Review: neuropathology of non-tau frontotemporal lobar degeneration. Neuropathol Appl Neurobiol, 45, 19&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">30357887</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney N.T., Spina S. and Miller B.L. (2017) Frontotemporal Dementia. Neurol Clin, 35, 339&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5472209</ArticleId><ArticleId IdType="pubmed">28410663</ArticleId></ArticleIdList></Reference><Reference><Citation>Finger E.C. (2016) Frontotemporal Dementias. Continuum (Minneap Minn), 22, 464&#x2013;489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5390934</ArticleId><ArticleId IdType="pubmed">27042904</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang J., Spina S. and Miller B.L. (2015) Frontotemporal dementia. Lancet, 386, 1672&#x2013;1682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5970949</ArticleId><ArticleId IdType="pubmed">26595641</ArticleId></ArticleIdList></Reference><Reference><Citation>Seltman R.E. and Matthews B.R. (2012) Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management. CNS Drugs, 26, 841&#x2013;870.</Citation><ArticleIdList><ArticleId IdType="pubmed">22950490</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann D.M.A. and Snowden J.S. (2017) Frontotemporal lobar degeneration: pathogenesis, pathology and pathways to phenotype. Brain Pathol, 27, 723&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pubmed">28100023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lashley T., Rohrer J.D., Mead S. and Revesz T. (2015) Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations. Neuropathol Appl Neurobiol, 41, 858&#x2013;881.</Citation><ArticleIdList><ArticleId IdType="pubmed">26041104</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chio A. and Traynor B.J. (2018) Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol, 17, 94&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P., Couratier P., Blasco H., Andres C.R., Beltran S., Meininger V. and Vourc'h P. (2017) Genetics of amyotrophic lateral sclerosis. Rev Neurol (Paris), 173, 254&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">28449881</ArticleId></ArticleIdList></Reference><Reference><Citation>Rainero I., Rubino E., Michelerio A., D'Agata F., Gentile S. and Pinessi L. (2017) Recent advances in the molecular genetics of frontotemporal lobar degeneration. Funct Neurol, 32, 7&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5505533</ArticleId><ArticleId IdType="pubmed">28380318</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C., Ravenscroft T.A., Sanchez-Contreras M. and Rademakers R. (2016) Genetics of FTLD: overview and what else we can expect from genetic studies. J Neurochem, 138(Suppl 1), 32&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">27009575</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J. Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T. et al. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science, 323, 1205&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P. et al. (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science, 323, 1208&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E. et al. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science, 319, 1668&#x2013;1672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F. et al. (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet, 40, 572&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Kim N.C., Wang Y.D., Scarborough E.A., Moore J., Diaz Z., MacLea K.S., Freibaum B., Li S., Molliex A. et al. (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature, 495, 467&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Nicholson A.M., Sarkar M., Messing J., Purice M.D., Pottier C., Annu K., Baker M., Perkerson R.B., Kurti A. et al. (2017) TIA1 mutations in amyotrophic lateral sclerosis and Frontotemporal dementia promote phase separation and Alter stress granule dynamics. Neuron, 95, 808, e809&#x2013;816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M. et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Rademakers R., Roeber S., Baker M., Kretzschmar H.A. and Mackenzie I.R. (2009) A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain, 132, 2922&#x2013;2931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768659</ArticleId><ArticleId IdType="pubmed">19674978</ArticleId></ArticleIdList></Reference><Reference><Citation>Rademakers R., Neumann M. and Mackenzie I.R. (2012) Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol, 8, 423&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3629543</ArticleId><ArticleId IdType="pubmed">22732773</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R. and Neumann M. (2016) Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies. J Neurochem, 138(Suppl 1), 54&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">27306735</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch-Reinshagen V., Pottier C., Nicholson A.M., Baker M., Hsiung G.R., Krieger C., Sengdy P., Boylan K.B., Dickson D.W., Mesulam M. et al. (2017) Clinical and neuropathological features of ALS/FTD with TIA1 mutations. Acta Neuropathol Commun, 5, 96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5719900</ArticleId><ArticleId IdType="pubmed">29216908</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J. and Taylor J.P. (2017) Lost in transportation: Nucleocytoplasmic transport defects in ALS and other neurodegenerative diseases. Neuron, 96, 285&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5678982</ArticleId><ArticleId IdType="pubmed">29024655</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M. and Cleveland D.W. (2010) TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet, 19, R46&#x2013;R64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Coady T.H. and Manley J.L. (2015) ALS mutations in TLS/FUS disrupt target gene expression. Genes Dev, 29, 1696&#x2013;1706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4561479</ArticleId><ArticleId IdType="pubmed">26251528</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden H.A. and Dormann D. (2016) Altered mRNP granule dynamics in FTLD pathogenesis. J Neurochem, 138(Suppl 1), 112&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">26938019</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangwan S. and Eisenberg D.S. (2016) Perspective on SOD1 mediated toxicity in amyotrophic lateral sclerosis. Postepy Biochem, 62, 362&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">28132491</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman J.M., Fernando S.M., Grad L.I., Hill A.F., Turner B.J., Yerbury J.J. and Cashman N.R. (2016) Disease mechanisms in ALS: Misfolded SOD1 transferred through exosome-dependent and exosome-independent pathways. Cell Mol Neurobiol, 36, 377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">26908139</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters O.M., Ghasemi M. and Brown R.H. Jr. (2015) Emerging mechanisms of molecular pathology in ALS. J Clin Invest, 125, 1767&#x2013;1779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4463186</ArticleId><ArticleId IdType="pubmed">25932674</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S., Vande Velde C. and Cleveland D.W. (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron, 52, 39&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook C. and Petrucelli L. (2019) Genetic convergence brings clarity to the enigmatic red line in ALS. Neuron, 101, 1057&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pubmed">30897357</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R. and Isaacs A.M. (2018) C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol, 14, 544&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron T.F. and Petrucelli L. (2018) Disease mechanisms of C9ORF72 repeat expansions. Cold Spring Harb Perspect Med, 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5880161</ArticleId><ArticleId IdType="pubmed">28130314</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin Y. and Brangwynne C.P. (2017) Liquid phase condensation in cell physiology and disease. Science, 357.</Citation><ArticleIdList><ArticleId IdType="pubmed">28935776</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain A. and Vale R.D. (2017) RNA phase transitions in repeat expansion disorders. Nature, 546, 243&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5555642</ArticleId><ArticleId IdType="pubmed">28562589</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M., Shang Y., Araki Y., Guo T., Huganir R.L. and Zhang M. (2016) Phase transition in postsynaptic densities underlies formation of synaptic complexes and synaptic plasticity. Cell, 166, 1163, e1112&#x2013;1175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5564291</ArticleId><ArticleId IdType="pubmed">27565345</ArticleId></ArticleIdList></Reference><Reference><Citation>Milovanovic D., Wu Y., Bian X. and De Camilli P. (2018) A liquid phase of synapsin and lipid vesicles. Science, 361, 604&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6191856</ArticleId><ArticleId IdType="pubmed">29976799</ArticleId></ArticleIdList></Reference><Reference><Citation>Snead D. and Eliezer D. (2019) Intrinsically disordered proteins in synaptic vesicle trafficking and release. J Biol Chem, 294, 3325&#x2013;3342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6416451</ArticleId><ArticleId IdType="pubmed">30700558</ArticleId></ArticleIdList></Reference><Reference><Citation>
Liao Y.C., Fernandopulle M., Guozhen Wang G., Choi H., Hao L., Drerup C.M., Qamar S., Nixon-Abell J., Shen Y., Meadows W.P. et al.  (2019) RNA granules hitchhike on lysosomes for long-distance transport, using annexin A11 as a molecular tether. Cell, https://ssrn.com/abstract=3312723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6890474</ArticleId><ArticleId IdType="pubmed">31539493</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeron-Sandoval L.P., Safaee N. and Michnick S.W. (2016) Mechanisms and consequences of macromolecular phase separation. Cell, 165, 1067&#x2013;1079.</Citation><ArticleIdList><ArticleId IdType="pubmed">27203111</ArticleId></ArticleIdList></Reference><Reference><Citation>Brangwynne C.P., Tompa P. and Pappu R.V. (2015) Polymer physics of intracellular phase transitions. Nat Phys, 11, 899&#x2013;904.</Citation></Reference><Reference><Citation>Pak C.W., Kosno M., Holehouse A.S., Padrick S.B., Mittal A., Ali R., Yunus A.A., Liu D.R., Pappu R.V. and Rosen M.K. (2016) Sequence determinants of intracellular phase separation by complex Coacervation of a disordered protein. Mol Cell, 63, 72&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4973464</ArticleId><ArticleId IdType="pubmed">27392146</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei M.T., Elbaum-Garfinkle S., Holehouse A.S., Chen C.C., Feric M., Arnold C.B., Priestley R.D., Pappu R.V. and Brangwynne C.P. (2017) Phase behaviour of disordered proteins underlying low density and high permeability of liquid organelles. Nat Chem, 9, 1118&#x2013;1125.</Citation><ArticleIdList><ArticleId IdType="pubmed">29064502</ArticleId></ArticleIdList></Reference><Reference><Citation>Banani S.F., Lee H.O., Hyman A.A. and Rosen M.K. (2017) Biomolecular condensates: organizers of cellular biochemistry. Nat Rev Mol Cell Biol, 18, 285&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434221</ArticleId><ArticleId IdType="pubmed">28225081</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon R.M., Chong P.A., Tsang B., Kim T.H., Bah A., Farber P., Lin H. and Forman-Kay J.D. (2018) Pi-pi contacts are an overlooked protein feature relevant to phase separation. Elife, 7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5847340</ArticleId><ArticleId IdType="pubmed">29424691</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmon T.S., Holehouse A.S., Rosen M.K. and Pappu R.V. (2017) Intrinsically disordered linkers determine the interplay between phase separation and gelation in multivalent proteins. Elife, 6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5703641</ArticleId><ArticleId IdType="pubmed">29091028</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Currie S.L. and Rosen M.K. (2017) Intrinsically disordered sequences enable modulation of protein phase separation through distributed tyrosine motifs. J Biol Chem, 292, 19110&#x2013;19120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5704491</ArticleId><ArticleId IdType="pubmed">28924037</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S., Wang G., Randle S.J., Ruggeri F.S., Varela J.A., Lin J.Q., Phillips E.C., Miyashita A., Williams D., Strohl F. et al. (2018) FUS phase separation is modulated by a molecular chaperone and methylation of arginine Cation-pi interactions. Cell, 173, 720, e715&#x2013;734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Tourriere H., Chebli K., Zekri L., Courselaud B., Blanchard J.M., Bertrand E. and Tazi J. (2003) The RasGAP-associated endoribonuclease G3BP assembles stress granules. J Cell Biol, 160, 823&#x2013;831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2173781</ArticleId><ArticleId IdType="pubmed">12642610</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella A.E., Zerze G.H., Mittal J. and Fawzi N.L. (2016) ALS mutations disrupt phase separation mediated by alpha-helical structure in the TDP-43 low-complexity C-terminal domain. Structure, 24, 1537&#x2013;1549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A., Conicella A.E., Schmidt H.B., Martin E.W., Rhoads S.N., Reeb A.N., Nourse A., Ramirez Montero D., Ryan V.H., Rohatgi R. et al. (2018) A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. EMBO J, 37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5830921</ArticleId><ArticleId IdType="pubmed">29438978</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Choi J.M., Holehouse A.S., Lee H.O., Zhang X., Jahnel M., Maharana S., Lemaitre R., Pozniakovsky A., Drechsel D. et al. (2018) A molecular grammar governing the driving forces for phase separation of prion-like RNA binding proteins. Cell, 174, 688, e616&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6063760</ArticleId><ArticleId IdType="pubmed">29961577</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes M.P., Sawaya M.R., Boyer D.R., Goldschmidt L., Rodriguez J.A., Cascio D., Chong L., Gonen T. and Eisenberg D.S. (2018) Atomic structures of low-complexity protein segments reveal kinked &#x3b2; sheets that assemble networks. Science, 359, 698&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6192703</ArticleId><ArticleId IdType="pubmed">29439243</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray D.T., Kato M., Lin Y., Thurber K.R., Hung I., McKnight S.L. and Tycko R. (2017) Structure of FUS protein fibrils and its relevance to self-assembly and phase separation of low-complexity domains. Cell, 171, 615, e616&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5650524</ArticleId><ArticleId IdType="pubmed">28942918</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes E. and Shorter J. (2019) The molecular language of membraneless organelles. J Biol Chem, 294, 7115&#x2013;7127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6509512</ArticleId><ArticleId IdType="pubmed">30045872</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S. and Carra S. (2018) Quality control of Membraneless organelles. J Mol Biol, 430, 4711&#x2013;4729.</Citation><ArticleIdList><ArticleId IdType="pubmed">29758260</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Alberti S., Fawzi N.L., Mittag T., Polymenidou M., Rousseau F., Schymkowitz J., Shorter J., Wolozin B., Van Den Bosch L. et al. (2018) Protein phase separation: a new phase in cell biology. Trends Cell Biol, 28, 420&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6034118</ArticleId><ArticleId IdType="pubmed">29602697</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S., Wang J., Papadopoulos D.K., Richter D., Pozniakovsky A., Poser I., Bickle M., Rizk S., Guillen-Boixet J., Franzmann T.M. et al. (2018) RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science, 360, 918&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091854</ArticleId><ArticleId IdType="pubmed">29650702</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Malinovska L., Saha S., Wang J., Alberti S., Krishnan Y. and Hyman A.A. (2017) ATP as a biological hydrotrope. Science, 356, 753&#x2013;756.</Citation><ArticleIdList><ArticleId IdType="pubmed">28522535</ArticleId></ArticleIdList></Reference><Reference><Citation>Protter D.S. and Parker R. (2016) Principles and properties of stress granules. Trends Cell Biol, 26, 668&#x2013;679.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4993645</ArticleId><ArticleId IdType="pubmed">27289443</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigeoka T., Jung H., Jung J., Turner-Bridger B., Ohk J., Lin J.Q., Amieux P.S. and Holt C.E. (2016) Dynamic axonal translation in developing and mature visual circuits. Cell, 166, 181&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4930487</ArticleId><ArticleId IdType="pubmed">27321671</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt C.E. and Bullock S.L. (2009) Subcellular mRNA localization in animal cells and why it matters. Science, 326, 1212&#x2013;1216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785123</ArticleId><ArticleId IdType="pubmed">19965463</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt C.E. and Schuman E.M. (2013) The central dogma decentralized: new perspectives on RNA function and local translation in neurons. Neuron, 80, 648&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820025</ArticleId><ArticleId IdType="pubmed">24183017</ArticleId></ArticleIdList></Reference><Reference><Citation>Han T.W., Kato M., Xie S., Wu L.C., Mirzaei H., Pei J., Chen M., Xie Y., Allen J., Xiao G. et al. (2012) Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. Cell, 149, 768&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pubmed">22579282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M., Han T.W., Xie S., Shi K., Du X., Wu L.C., Mirzaei H., Goldsmith E.J., Longgood J., Pei J. et al. (2012) Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell, 149, 753&#x2013;767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T., Qamar S., Lin J.Q., Schierle G.S., Rees E., Miyashita A., Costa A.R., Dodd R.B., Chan F.T., Michel C.H. et al. (2015) ALS/FTD mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function. Neuron, 88, 678&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A., Temirov J., Lee J., Coughlin M., Kanagaraj A.P., Kim H.J., Mittag T. and Taylor J.P. (2015) Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell, 163, 123&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H.O., Jawerth L., Maharana S., Jahnel M., Hein M.Y., Stoynov S., Mahamid J., Saha S., Franzmann T.M. et al. (2015) A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell, 162, 1066&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt H.B. and Rohatgi R. (2016) In vivo formation of vacuolated multi-phase compartments lacking membranes. Cell Rep, 16, 1228&#x2013;1236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4972689</ArticleId><ArticleId IdType="pubmed">27452472</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz J.C., Cech T.R. and Parker R.R. (2015) Biochemical properties and biological functions of FET proteins. Annu Rev Biochem, 84, 355&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">25494299</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A. and Buratti E. (2016) Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J Neurochem, 138(Suppl 1), 95&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Madl T., Valori C.F., Bentmann E., Tahirovic S., Abou-Ajram C., Kremmer E., Ansorge O., Mackenzie I.R., Neumann M. et al. (2012) Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. EMBO J, 31, 4258&#x2013;4275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3501225</ArticleId><ArticleId IdType="pubmed">22968170</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Rodde R., Edbauer D., Bentmann E., Fischer I., Hruscha A., Than M.E., Mackenzie I.R., Capell A., Schmid B. et al. (2010) ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J, 29, 2841&#x2013;2857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez-Calvet M., Neumann M., Arzberger T., Abou-Ajram C., Funk E., Hartmann H., Edbauer D., Kremmer E., Gobl C., Resch M. et al. (2016) Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS. Acta Neuropathol, 131, 587&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">26895297</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C.F. and Yu G. (2015) The function of RNA-binding proteins at the synapse: implications for neurodegeneration. Cell Mol Life Sci, 72, 3621&#x2013;3635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4565867</ArticleId><ArticleId IdType="pubmed">26047658</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D. and Haass C. (2013) Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration. Mol Cell Neurosci, 56, 475&#x2013;486.</Citation><ArticleIdList><ArticleId IdType="pubmed">23557964</ArticleId></ArticleIdList></Reference><Reference><Citation>Cioni J.M., Lin J.Q., Holtermann A.V., Koppers M., Jakobs M.A.H., Azizi A., Turner-Bridger B., Shigeoka T., Franze K., Harris W.A. et al. (2019) Late endosomes act as mRNA translation platforms and sustain mitochondria in axons. Cell, 176, 56, e15&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6333918</ArticleId><ArticleId IdType="pubmed">30612743</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappsilber J., Friesen W.J., Paushkin S., Dreyfuss G. and Mann M. (2003) Detection of arginine dimethylated peptides by parallel precursor ion scanning mass spectrometry in positive ion mode. Anal Chem, 75, 3107&#x2013;3114.</Citation><ArticleIdList><ArticleId IdType="pubmed">12964758</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanikawa C., Ueda K., Suzuki A., Iida A., Nakamura R., Atsuta N., Tohnai G., Sobue G., Saichi N., Momozawa Y. et al. (2018) Citrullination of RGG motifs in FET proteins by PAD4 regulates protein aggregation and ALS susceptibility. Cell Rep, 22, 1473&#x2013;1483.</Citation><ArticleIdList><ArticleId IdType="pubmed">29425503</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Q., Holler C.J., Taylor G., Hudson K.F., Watkins W., Gearing M., Ito D., Murray M.E., Dickson D.W., Seyfried N.T. et al. (2014) FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage. J Neurosci, 34, 7802&#x2013;7813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4044245</ArticleId><ArticleId IdType="pubmed">24899704</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz J.C., Wang X., Podell E.R. and Cech T.R. (2013) RNA seeds higher-order assembly of FUS protein. Cell Rep, 5, 918&#x2013;925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3925748</ArticleId><ArticleId IdType="pubmed">24268778</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z., Ryan V.H., Janke A.M., Burke K.A., Rhoads S.N., Zerze G.H., O'Meally R., Dignon G.L., Conicella A.E., Zheng W. et al. (2017) Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J, in press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Martinez F.J. and Yeo G.W. (2017) Genetic mutations in RNA-binding proteins and their roles in ALS. Hum Genet, 136, 1193&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Hortobagyi T. and Cairns N.J. (2017) Amyotrophic lateral sclerosis and non-tau frontotemporal lobar degeneration. Handb Clin Neurol, 145, 369&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">28987183</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Valori C.F., Ansorge O., Kretzschmar H.A., Munoz D.G., Kusaka H., Yokota O., Ishihara K., Ang L.C., Bilbao J.M. et al. (2012) Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations. Acta Neuropathol, 124, 705&#x2013;716.</Citation><ArticleIdList><ArticleId IdType="pubmed">22842875</ArticleId></ArticleIdList></Reference><Reference><Citation>Troakes C., Hortobagyi T., Vance C., Al-Sarraj S., Rogelj B. and Shaw C.E. (2013) Transportin 1 colocalization with fused in sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS inclusions. Neuropathol Appl Neurobiol, 39, 553&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">22934812</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Erauskin J., Tadokoro T., Baughn M.W., Myers B., McAlonis-Downes M., Chillon-Marinas C., Asiaban J.N., Artates J., Bui A.T., Vetto A.P. et al. (2018) ALS/FTD-linked mutation in FUS suppresses intra-axonal protein synthesis and drives disease without nuclear loss-of-function of FUS. Neuron, 100, 816, e817&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6277851</ArticleId><ArticleId IdType="pubmed">30344044</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y. et al. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun., 351, 602&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M. et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E.B., Lee V.M.Y. and Trojanowski J.Q. (2012) Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nature Reviews Neuroscience, 13, 38&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A. and Buratti E. (2016) Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J. Neurochem., 138, 95&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Martinez F.J. and Yeo G.W. (2017) Genetic mutations in RNA-binding proteins and their roles in ALS. Hum. Genet., 136, 1193&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T., Hock E.M., Ernst P., Foglieni C., Jambeau M., Gilhespy L.A.B., Laferriere F., Maniecka Z., Pluckthun A., Mittl P. et al. (2017) Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nature Communications, 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Kang J., Lim L.Z., Wei Y.Y. and Song J.X. (2018) TDP-43 NTD can be induced while CTD is significantly enhanced by ssDNA to undergo liquid-liquid phase separation. Biochem. Biophys. Res. Commun., 499, 189&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">29555476</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A., Temirov J., Lee J., Coughlin M., Kanagaraj A.P., Kim H.J., Mittag T. and Taylor J.P. (2015) Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell, 163, 123&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt H.B. and Rohatgi R. (2016) In vivo formation of vacuolated multi-phase compartments lacking membranes. Cell Reports, 16, 1228&#x2013;1236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4972689</ArticleId><ArticleId IdType="pubmed">27452472</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H.R., Chiang W.C., Chou P.C., Wang W.J. and Huang J.R. (2018) TAR DNA-binding protein 43 (TDP-43) liquid-liquid phase separation is mediated by just a few aromatic residues. J. Biol. Chem., 293, 6090&#x2013;6098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5912450</ArticleId><ArticleId IdType="pubmed">29511089</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H.R., Chen T.C., Hsiao C.L., Shi L., Chou C.Y. and Huang J.R. (2018) The physical forces mediating self-association and phase-separation in the C-terminal domain of TDP-43. Biochimica Et Biophysica Acta-Proteins and Proteomics, 1866, 214&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">28988034</ArticleId></ArticleIdList></Reference><Reference><Citation>Guenther E.L., Cao Q., Trinh H., Lu J.H., Sawaya M.R., Cascio D., Boyer D.R., Rodriguez J.A., Hughes M.P. and Eisenberg D.S. (2018) Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation. Nat. Struct. Mol. Biol., 25, 463&#x2013;+.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5990464</ArticleId><ArticleId IdType="pubmed">29786080</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami N.H., Smith R.B., Carrasco M.A., Williams L.A., Winborn C.S., Han S.S.W., Kiskinis E., Winborn B., Freibaum B.D., Kanagaraj A. et al. (2014) Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron, 81, 536&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L., Lin A.Y., Ebata A., Boon J.Y., Reid W., Xu Y.F., Kobrin K., Murphy G.J., Petrucelli L. and Wolozin B. (2014) ALS-linked mutations enlarge TDP-43-enriched neuronal RNA granules in the dendritic arbor. J Neurosci, 34, 4167&#x2013;4174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3960463</ArticleId><ArticleId IdType="pubmed">24647938</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores B.N., Li X.L., Malik A.M., Martinez J., Beg A.A. and Barmada S.J. (2019) An Intramolecular salt bridge linking TDP43 RNA binding, protein stability, and TDP43-dependent Neurodegeneration. Cell Reports, 27, 1133&#x2013;1150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6499398</ArticleId><ArticleId IdType="pubmed">31018129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihara R., Matsukawa K., Nagata Y., Kunugi H., Tsuji S., Chihara T., Kuranaga E., Miura M., Wakabayashi T., Hashimoto T. et al. (2013) RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy. Hum. Mol. Genet., 22, 4474&#x2013;4484.</Citation><ArticleIdList><ArticleId IdType="pubmed">23804749</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt A., Herholz D., Fiesel F.C., Kaur K., Muller D., Karsten P., Weber S.S., Kahle P.J., Marquardt T. and Schulz J.B. (2010) TDP-43-mediated neuron loss in vivo requires RNA-binding activity. Plos One, 5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2923622</ArticleId><ArticleId IdType="pubmed">20806063</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino E., Rainero I., Chio A., Rogaeva E., Galimberti D., Fenoglio P., Grinberg Y., Isaia G., Calvo A., Gentile S. et al. (2012) SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology, 79, 1556&#x2013;1562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3655323</ArticleId><ArticleId IdType="pubmed">22972638</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady O.A., Meng P., Zheng Y.Q., Mao Y.X. and Hu F.H. (2011) Regulation of TDP-43 aggregation by phosphorylation andp62/SQSTM1. J. Neurochem., 116, 248&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">21062285</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanji K., Zhang H.X., Mori F., Kakita A., Takahashi H. and Wakabayashi K. (2012) p62/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions. J. Neurosci. Res., 90, 2034&#x2013;2042.</Citation><ArticleIdList><ArticleId IdType="pubmed">22674379</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushimura Y., Tokuda T., Azuma Y., Yamamoto I., Mizuta I., Mizuno T., Nakagawa M., Ueyama M., Nagai Y., Yoshida H. et al. (2018) Overexpression of ter94, Drosophila VCP, improves motor neuron degeneration induced by knockdown of TBPH, Drosophila TDP-43. Am J Neurodegener Dis, 7, 11&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5840287</ArticleId><ArticleId IdType="pubmed">29531866</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritson G.P., Custer S.K., Freibaum B.D., Guinto J.B., Geffel D., Moore J., Tang W., Winton M.J., Neumann M., Trojanowski J.Q. et al. (2010) TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. J Neurosci, 30, 7729&#x2013;7739.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2890254</ArticleId><ArticleId IdType="pubmed">20519548</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho M.A., Strider J., Carter D., Taylor-Reinwald L., Forman M.S., Goate A.M. and Cairns N.J. (2009) VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. J Biol Chem, 284, 12384&#x2013;12398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2673306</ArticleId><ArticleId IdType="pubmed">19237541</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Ortiz C.J., Hoshino H., Cheng D., Liu-Yescevitz L., Blurton-Jones M., Wolozin B., LaFerla F.M. and Kitazawa M. (2013) Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice. Am J Pathol, 183, 504&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3730785</ArticleId><ArticleId IdType="pubmed">23747512</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A.C., Kim H.J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X.D., Armakola M., Geser F., Greene R., Lu M.M. et al. (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature, 466, 1069&#x2013;U1077.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker L.A., Huang B., Bieri G., Ma R., Knowles D.A., Jafar-Nejad P., Messing J., Kim H.J., Soriano A., Auburger G. et al. (2017) Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature, 544, 367&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5642042</ArticleId><ArticleId IdType="pubmed">28405022</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakthavachalu B., Huelsmeier J., Sudhakaran I.P., Hillebrand J., Singh A., Petrauskas A., Thiagarajan D., Sankaranarayanan M., Mizoue L., Anderson E.N. et al. (2018) RNP-granule assembly via Ataxin-2 disordered domains is required for long-term memory and Neurodegeneration. Neuron, 98, 754, e754&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pubmed">29772202</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B.N., Topp S.D., Fallini C., Shibata H., Chen H.J., Troakes C., King A., Ticozzi N., Kenna K.P., Soragia-Gkazi A. et al. (2017) Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Sci Transl Med, 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6599403</ArticleId><ArticleId IdType="pubmed">28469040</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Liu Q., Liu K., Shen D., Tai H., Shu S., Ding Q., Fu H., Liu S., Wang Z. et al. (2018) ANXA11 mutations prevail in Chinese ALS patients with and without cognitive dementia. Neurol Genet, 4, e237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5963931</ArticleId><ArticleId IdType="pubmed">29845112</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>